UK markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.50000.0000 (0.00%)
At close: 10:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.38M
Enterprise value -2.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.32
Price/book (mrq)1.03
Enterprise value/revenue -4.63
Enterprise value/EBITDA 0.15

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-27.54%
S&P500 52-week change 322.64%
52-week high 32.5000
52-week low 30.5000
50-day moving average 30.5800
200-day moving average 30.6040

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5853.42k
Implied shares outstanding 63.53M
Float 8616.15k
% held by insiders 133.23%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)3,176.63%

Management effectiveness

Return on assets (ttm)-19.46%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)339.23k
Revenue per share (ttm)0.40
Quarterly revenue growth (yoy)-86.70%
Gross profit (ttm)N/A
EBITDA -3.61M
Net income avi to common (ttm)-4.46M
Diluted EPS (ttm)-21.1500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.1M
Total cash per share (mrq)2.47
Total debt (mrq)11.89M
Total debt/equity (mrq)N/A
Current ratio (mrq)9.03
Book value per share (mrq)-9.39

Cash flow statement

Operating cash flow (ttm)-5.71M
Levered free cash flow (ttm)-2.48M